JPH0559919B2 - - Google Patents
Info
- Publication number
- JPH0559919B2 JPH0559919B2 JP59274249A JP27424984A JPH0559919B2 JP H0559919 B2 JPH0559919 B2 JP H0559919B2 JP 59274249 A JP59274249 A JP 59274249A JP 27424984 A JP27424984 A JP 27424984A JP H0559919 B2 JPH0559919 B2 JP H0559919B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- dimethyl
- dione
- atom
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 18
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 17
- 125000001309 chloro group Chemical group Cl* 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 9
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 8
- 125000001153 fluoro group Chemical group F* 0.000 claims abstract description 8
- 125000002252 acyl group Chemical group 0.000 claims abstract description 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims abstract description 6
- 150000003431 steroids Chemical class 0.000 claims description 13
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 229920006395 saturated elastomer Polymers 0.000 claims description 5
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 4
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- RJKFOVLPORLFTN-UHFFFAOYSA-N progesterone acetate Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2 RJKFOVLPORLFTN-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- CUILPNURFADTPE-UHFFFAOYSA-N hypobromous acid Chemical compound BrO CUILPNURFADTPE-UHFFFAOYSA-N 0.000 claims description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 2
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract description 3
- 125000004423 acyloxy group Chemical group 0.000 abstract description 2
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 abstract description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 238000002844 melting Methods 0.000 description 15
- 230000008018 melting Effects 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 6
- 235000012239 silicon dioxide Nutrition 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000010626 work up procedure Methods 0.000 description 5
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- -1 alkanoyl radicals Chemical class 0.000 description 4
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- FGWYWKIOMUZSQF-UHFFFAOYSA-N 1,1,1-triethoxypropane Chemical compound CCOC(CC)(OCC)OCC FGWYWKIOMUZSQF-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- MOQOOKGPCBQMCY-UHFFFAOYSA-N acetic acid;hexane Chemical compound CC(O)=O.CCCCCC MOQOOKGPCBQMCY-UHFFFAOYSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- IVGJVBYYHSUZEQ-XUCMERPOSA-N (8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-prop-2-enoyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C=CC([C@H]1CC[C@H]2[C@@H]3CCC4=CC(CC[C@]4(C)[C@H]3CC[C@]12C)=O)=O IVGJVBYYHSUZEQ-XUCMERPOSA-N 0.000 description 1
- KOPMZTKUZCNGFY-UHFFFAOYSA-N 1,1,1-triethoxybutane Chemical compound CCCC(OCC)(OCC)OCC KOPMZTKUZCNGFY-UHFFFAOYSA-N 0.000 description 1
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- NHFYMIGVCXFADG-PWANINPKSA-N [(8s,9s,10r,11s,13s,14s,16r,17r)-17-(2-acetyloxyacetyl)-17-hydroxy-10,13,16-trimethyl-6-methylidene-3-oxo-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-11-yl] 2,2,2-trifluoroacetate Chemical compound C1C(=C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)COC(C)=O)(O)[C@@]1(C)C[C@@H]2OC(=O)C(F)(F)F NHFYMIGVCXFADG-PWANINPKSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- HASGOCLZFTZSTN-UHFFFAOYSA-N cyclohexane;hexane Chemical compound CCCCCC.C1CCCCC1 HASGOCLZFTZSTN-UHFFFAOYSA-N 0.000 description 1
- FDSGHYHRLSWSLQ-UHFFFAOYSA-N dichloromethane;propan-2-one Chemical compound ClCCl.CC(C)=O FDSGHYHRLSWSLQ-UHFFFAOYSA-N 0.000 description 1
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 201000011486 lichen planus Diseases 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
- BQFPCTXLBRVFJL-UHFFFAOYSA-N triethoxymethylbenzene Chemical compound CCOC(OCC)(OCC)C1=CC=CC=C1 BQFPCTXLBRVFJL-UHFFFAOYSA-N 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
ç£æ¥äžã®å©çšåé
æ¬çºæã¯ãäžè¬åŒïŒ
ãåŒäžçµåæãã¯åçµååã¯äºéçµåãè¡šããã
ã¯æ°ŽçŽ ååãåŒçŽ ååãå¡©çŽ åååã¯èçŽ åå
ãè¡šãããR1ã¯ççŽ ååïŒãïŒåãæããã¢ã«
ã«ãã€ã«åºåã¯ãã³ãŸã€ã«åºãè¡šãããã¯æ°ŽçŽ
ååãå¡©çŽ ååãããããã·åºããã«ãã«åºãç
çŽ ååïŒãïŒåãæããã¢ã«ã«ãã€ã«ãªãã·åºå
ã¯ãã³ãŸã€ã«ãªãã·åºãè¡šãããã§ç€ºãããïŒïŒ
16âãžã¡ãã«ã³ã«ãã³ã€ãã該ååç©ã®è£œé æ¹æ³
åã³åèšïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€ããåæã
ãããã®äžéç©è³ªãšããŠäœ¿çšãããã¹ããã€ãã«
é¢ããã
ã¯æ°ŽçŽ ååãåŒçŽ ååãå¡©çŽ åååã¯èçŽ åå
ãè¡šãããR1ã¯ççŽ ååïŒãïŒåãæããã¢ã«
ã«ãã€ã«åºåã¯ãã³ãŸã€ã«åºãè¡šãããã¯æ°ŽçŽ
ååãå¡©çŽ ååãããããã·åºããã«ãã«åºãç
çŽ ååïŒãïŒåãæããã¢ã«ã«ãã€ã«ãªãã·åºå
ã¯ãã³ãŸã€ã«ãªãã·åºãè¡šãããã§ç€ºãããïŒïŒ
16âãžã¡ãã«ã³ã«ãã³ã€ãã該ååç©ã®è£œé æ¹æ³
åã³åèšïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€ããåæã
ãããã®äžéç©è³ªãšããŠäœ¿çšãããã¹ããã€ãã«
é¢ããã
æ°èŠïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€ãã¯ã眮æåº
R1ãšããŠççŽ ååïŒãïŒåãæããã¢ã«ã«ãã€
ã«åºåã¯ãã³ãŸã€ã«åºãæããããšãã§ãããé©
åœãªã¢ã«ã«ãã€ã«åºR1ã¯äŸãã°ã¢ã»ãã«åºãã
ãããªãã«åºåã¯ãããªã«åºã§ããã
R1ãšããŠççŽ ååïŒãïŒåãæããã¢ã«ã«ãã€
ã«åºåã¯ãã³ãŸã€ã«åºãæããããšãã§ãããé©
åœãªã¢ã«ã«ãã€ã«åºR1ã¯äŸãã°ã¢ã»ãã«åºãã
ãããªãã«åºåã¯ãããªã«åºã§ããã
眮æåºïŒ¹ãšããŠã¯ãæ°ŽçŽ ååãå¡©çŽ ååããã
ããã·åºåã¯ã¢ã»ããã·åºãæããããšãã§ã
ãã
ããã·åºåã¯ã¢ã»ããã·åºãæããããšãã§ã
ãã
äžè¬åŒã«ããïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€ã
ã¯ãå±æé©çšã®éã«æ矀ã®æççæ§ã«ãã€ãŠåªã
ãŠãããããã«è©²ååç©ã¯ææã®å±æå¹èœãšäžæ
æã®èº«äœçå¯äœçšãšã®éã®åªç§ãªåé¢ã瀺ãã
ã¯ãå±æé©çšã®éã«æ矀ã®æççæ§ã«ãã€ãŠåªã
ãŠãããããã«è©²ååç©ã¯ææã®å±æå¹èœãšäžæ
æã®èº«äœçå¯äœçšãšã®éã®åªç§ãªåé¢ã瀺ãã
äžè¬åŒã«ããããæ°ŽçŽ ååãåŒçŽ åååã¯
å¡©çŽ ååãè¡šãã該ïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€
ãã¯ããèçŽ ååãè¡šãããã®ãããè¬å€åŠç
補å€ã§äœ¿çšããã«ã¯é©åœã§ããããããšããã®ã
åŸè ã®ååç©ã¯ã¬ãŒã¬ã³åŒèª¿å€äžã§ã¯ããŸãå®å®
ã§ã¯ãªãããã§ããããããäžè¬åŒã®ïŒâãã
ã ã¹ããã€ãã¯ãæ¬çºæã«ãããã®ä»ã®è¬çäœçš
ãæããïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€ãã®åæã®
ããã®æå¹ãªäžéç©è³ªã§ããã
å¡©çŽ ååãè¡šãã該ïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€
ãã¯ããèçŽ ååãè¡šãããã®ãããè¬å€åŠç
補å€ã§äœ¿çšããã«ã¯é©åœã§ããããããšããã®ã
åŸè ã®ååç©ã¯ã¬ãŒã¬ã³åŒèª¿å€äžã§ã¯ããŸãå®å®
ã§ã¯ãªãããã§ããããããäžè¬åŒã®ïŒâãã
ã ã¹ããã€ãã¯ãæ¬çºæã«ãããã®ä»ã®è¬çäœçš
ãæããïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€ãã®åæã®
ããã®æå¹ãªäžéç©è³ªã§ããã
äžè¬åŒã®æ°èŠïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€ã
ã¯ãã¬ãŒã¬ã³åŒè¬å€æ³ã§åžžçšã®è³Šåœ¢å€ãšã®çµåã
ã§ãæ¥è§Šç®èçãçš®ã ã®æ¹¿ç¹ãç¥çµç®èçãçŽ ç®
çãç«å·ãå€é°åã³ã¢ãïŒaniïŒççãé æ»ç®ã
ç®èçŽ æã也ç¬ãæå¹³åã³ç£ç¶èç¬åã³é¡äŒŒã®ç®
èç ã®å±æçæ²»çã«é©åœã§ããã
ã¯ãã¬ãŒã¬ã³åŒè¬å€æ³ã§åžžçšã®è³Šåœ¢å€ãšã®çµåã
ã§ãæ¥è§Šç®èçãçš®ã ã®æ¹¿ç¹ãç¥çµç®èçãçŽ ç®
çãç«å·ãå€é°åã³ã¢ãïŒaniïŒççãé æ»ç®ã
ç®èçŽ æã也ç¬ãæå¹³åã³ç£ç¶èç¬åã³é¡äŒŒã®ç®
èç ã®å±æçæ²»çã«é©åœã§ããã
ç¹æ®è¬å€ã®è£œé ã¯ãåžžæ³ã§ãäœçšç©è³ªãé©åœãª
æ·»å ç©ãšå ±ã«ææã®é©çšåœ¢ãäŸãã°æº¶æ¶²ãããŒã·
ãšã³ãè»ãããã¯ãªãŒã åã¯ããè¬ã«å€ããããš
ã«ãã€ãŠè¡ãããããã®ããã«ããŠè£œå€ããè¬å€
ã«ãããŠäœçšç©è³ªã®æ¿åºŠã¯é©çšåœ¢ã«äŸåãããã
ãŒã·ãšã³åã³è»ããã®å Žåã«ã¯ã奜ãŸããã¯
0.001ãïŒïŒ ã®äœçšç©è³ªæ¿åºŠã䜿çšãããã
æ·»å ç©ãšå ±ã«ææã®é©çšåœ¢ãäŸãã°æº¶æ¶²ãããŒã·
ãšã³ãè»ãããã¯ãªãŒã åã¯ããè¬ã«å€ããããš
ã«ãã€ãŠè¡ãããããã®ããã«ããŠè£œå€ããè¬å€
ã«ãããŠäœçšç©è³ªã®æ¿åºŠã¯é©çšåœ¢ã«äŸåãããã
ãŒã·ãšã³åã³è»ããã®å Žåã«ã¯ã奜ãŸããã¯
0.001ãïŒïŒ ã®äœçšç©è³ªæ¿åºŠã䜿çšãããã
ããã«æ°èŠååç©ã¯ãå Žåã«ãã€ãŠã¯åžžçšã®è³Š
圢å€åã³å©å€ãšã®çµåãã§ãæ°ç®¡ã®ã¢ã¬ã«ã®ãŒæ§
çŸæ£ãäŸãã°æ°ç®¡æ¯åæ¯åã¯éŒ»çã®æ²»çã®ããã«
䜿çšããããšã®ã§ããåžå ¥å€ã®è£œé ã«å¥œé©ã§ã
ãã
圢å€åã³å©å€ãšã®çµåãã§ãæ°ç®¡ã®ã¢ã¬ã«ã®ãŒæ§
çŸæ£ãäŸãã°æ°ç®¡æ¯åæ¯åã¯éŒ»çã®æ²»çã®ããã«
䜿çšããããšã®ã§ããåžå ¥å€ã®è£œé ã«å¥œé©ã§ã
ãã
ãŸãæ°èŠã³ã«ãã³ã€ãã¯ãäœçšç©è³ªå¥œãŸããã¯
10ã200mgãå«æããã€çµå£é©çšãããã«ãã»ã«ã
é å€åã¯ç³è¡£äžžã®åœ¢åã¯åäœå®¹éããã奜ãŸãã
ã¯100ã500mgã®äœçšç©è³ªãå«æããã€çŽè žããé©
çšãããæžæ¿æ¶²ã®åœ¢ã§ãé©åœã§ããããŸãè žç®¡ã®
ã¢ã¬ã«ã®ãŒçŸæ£ãäŸãã朰çæ§åã³èèœè «æ§å€§è ž
çã®æ²»çã«ãé©åœã§ããã
10ã200mgãå«æããã€çµå£é©çšãããã«ãã»ã«ã
é å€åã¯ç³è¡£äžžã®åœ¢åã¯åäœå®¹éããã奜ãŸãã
ã¯100ã500mgã®äœçšç©è³ªãå«æããã€çŽè žããé©
çšãããæžæ¿æ¶²ã®åœ¢ã§ãé©åœã§ããããŸãè žç®¡ã®
ã¢ã¬ã«ã®ãŒçŸæ£ãäŸãã朰çæ§åã³èèœè «æ§å€§è ž
çã®æ²»çã«ãé©åœã§ããã
æ°èŠïŒïŒ16âãžã¡ãã«ã³ã«ã³ã«ãã³ã€ãã¯ãèª
äœå ¬ç¥ã®ããã«ã㊠(a) äžè¬åŒïŒ ãåŒäžããR1åã³ïŒ¹ã¯åèšã®ãã®ãè¡šãã
ã§ç€ºãããã¹ããã€ãã®ãšããã·ãç°ãåŒåæ°Ž
çŽ ãçšããŠéç°ãããå㯠(b) äžè¬åŒïŒ ãåŒäžããR1åã³ïŒ¹ã¯åèšã®ãã®ãè¡šããã
ã§ç€ºãããã¹ããããã®â³9(11)âäºéçµåã«æ¬¡
äºå¡©çŽ é žåã¯æ¬¡äºèçŽ é žãä»å ãããã€ææã®
å Žåã«ã¯äžè¬åŒã®ïŒâããã ã¹ããã€ããã
ïŒäœã«ååšããããã²ã³ååãé€å»ããïŒãïŒ
äœã§é£œåãããäžè¬åŒã®ã¹ããã€ãããã®äœ
眮ã§è±æ°ŽçŽ ããäžè¬åŒã®21âã¢ã»ããã·ã¹ã
ãã€ããå æ°Žå解ãåã¯äžè¬åŒã®21âãããã
ã·ã¹ããã€ãããšã¹ãã«åããããšãç¹åŸŽãšã
ãæ¹æ³ã«ãã€ãŠè£œé ããããããã®æ¹æ³ã¯è¥¿ç¬
åœç¹èš±åºé¡ç¬¬P2645105.8å·åã³ç¬¬P2803661.5å·
ã«èšèŒãããŠããæ¡ä»¶äžã§å®æœããããšãã§ã
ãã
äœå ¬ç¥ã®ããã«ã㊠(a) äžè¬åŒïŒ ãåŒäžããR1åã³ïŒ¹ã¯åèšã®ãã®ãè¡šãã
ã§ç€ºãããã¹ããã€ãã®ãšããã·ãç°ãåŒåæ°Ž
çŽ ãçšããŠéç°ãããå㯠(b) äžè¬åŒïŒ ãåŒäžããR1åã³ïŒ¹ã¯åèšã®ãã®ãè¡šããã
ã§ç€ºãããã¹ããããã®â³9(11)âäºéçµåã«æ¬¡
äºå¡©çŽ é žåã¯æ¬¡äºèçŽ é žãä»å ãããã€ææã®
å Žåã«ã¯äžè¬åŒã®ïŒâããã ã¹ããã€ããã
ïŒäœã«ååšããããã²ã³ååãé€å»ããïŒãïŒ
äœã§é£œåãããäžè¬åŒã®ã¹ããã€ãããã®äœ
眮ã§è±æ°ŽçŽ ããäžè¬åŒã®21âã¢ã»ããã·ã¹ã
ãã€ããå æ°Žå解ãåã¯äžè¬åŒã®21âãããã
ã·ã¹ããã€ãããšã¹ãã«åããããšãç¹åŸŽãšã
ãæ¹æ³ã«ãã€ãŠè£œé ããããããã®æ¹æ³ã¯è¥¿ç¬
åœç¹èš±åºé¡ç¬¬P2645105.8å·åã³ç¬¬P2803661.5å·
ã«èšèŒãããŠããæ¡ä»¶äžã§å®æœããããšãã§ã
ãã
ãŸãæ¬çºæã«ããã°äžè¬åŒïœïŒ
ãåŒäžããåã³ïŒ¹ã¯åèšã®ãã®ãè¡šãããR2
ã¯æé«ïŒåã®ççŽ ååãæããã¢ã«ãã«åºåã¯ã
ãšãã«åºãè¡šãããã§ç€ºãããïŒïŒ16âãžã¡ãã«
ã³ã«ãã³ã€ãããèªäœå ¬ç¥ã®ããã«ããŠã (a) äžè¬åŒïŒ ãåŒäžããåã³R2ã¯åèšã®ãã®ãè¡šããã
R3ã¯ççŽ ååïŒãïŒåãæããã¢ã«ãã«åºã
è¡šãããã§ç€ºãããã¹ããã€ãã®ãªã«ããšã¹ã
ã«ããé žãããªã¡ãã«ã·ãªã«ã¯ããªãåã¯ããª
ããšãã«ã¡ãã«ã¯ããªããçšããŠå解ãããã
å㯠(b) äžè¬åŒïŒ ãåŒäžããåã³R2ã¯åèšã®ãã®ãè¡šããã
ã§ç€ºãããã¹ããã€ãã®21âã¢ã·ã«åºã転äœ
ãããã€å Žåã«ãã€ãŠã¯21äœã®ããããã·åºã
ãšã¹ãã«åãããåã¯æ°ŽçŽ åã¯å¡©çŽ ãšäº€æãã
ã€å Žåã«ãã€ãŠã¯ïŒãïŒäœã§é£œåãããã¹ãã
ã€ãããã®äœçœ®ã§è±æ°ŽçŽ ããããšã«ãã€ãŠè£œé
ããããšãã§ããã
ã¯æé«ïŒåã®ççŽ ååãæããã¢ã«ãã«åºåã¯ã
ãšãã«åºãè¡šãããã§ç€ºãããïŒïŒ16âãžã¡ãã«
ã³ã«ãã³ã€ãããèªäœå ¬ç¥ã®ããã«ããŠã (a) äžè¬åŒïŒ ãåŒäžããåã³R2ã¯åèšã®ãã®ãè¡šããã
R3ã¯ççŽ ååïŒãïŒåãæããã¢ã«ãã«åºã
è¡šãããã§ç€ºãããã¹ããã€ãã®ãªã«ããšã¹ã
ã«ããé žãããªã¡ãã«ã·ãªã«ã¯ããªãåã¯ããª
ããšãã«ã¡ãã«ã¯ããªããçšããŠå解ãããã
å㯠(b) äžè¬åŒïŒ ãåŒäžããåã³R2ã¯åèšã®ãã®ãè¡šããã
ã§ç€ºãããã¹ããã€ãã®21âã¢ã·ã«åºã転äœ
ãããã€å Žåã«ãã€ãŠã¯21äœã®ããããã·åºã
ãšã¹ãã«åãããåã¯æ°ŽçŽ åã¯å¡©çŽ ãšäº€æãã
ã€å Žåã«ãã€ãŠã¯ïŒãïŒäœã§é£œåãããã¹ãã
ã€ãããã®äœçœ®ã§è±æ°ŽçŽ ããããšã«ãã€ãŠè£œé
ããããšãã§ããã
該ïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€ãã®åæã®ãã
ã®äžéç©è³ªãšããŠã¯ãäžè¬åŒïŒ ãåŒäžR1åã³ïŒ¹ã¯åèšã®ãã®ãè¡šãããã¯æ°Ž
çŽ åååã¯ããªãã«ãªã«ã¢ã»ããã·åºãè¡šããã
R4åã³R5ã¯äžç·ã«ã¡ãã¬ã³åºãè¡šãããåã¯ïŒ
åã®æ°ŽçŽ ååãè¡šãããã§ç€ºãããã¹ããã€ãã
䜿çšãããã
ã®äžéç©è³ªãšããŠã¯ãäžè¬åŒïŒ ãåŒäžR1åã³ïŒ¹ã¯åèšã®ãã®ãè¡šãããã¯æ°Ž
çŽ åååã¯ããªãã«ãªã«ã¢ã»ããã·åºãè¡šããã
R4åã³R5ã¯äžç·ã«ã¡ãã¬ã³åºãè¡šãããåã¯ïŒ
åã®æ°ŽçŽ ååãè¡šãããã§ç€ºãããã¹ããã€ãã
䜿çšãããã
å®æœäŸ
äŸ ïŒ
(a) ã¡ã¿ããŒã«150mlåã³ããã©ããããã©ã³450
mläžã®21âã¢ã»ããã·âïŒâãã«ãªã«â17âã
ãããã·â16αâã¡ãã«â11βâããªãã«ãªã«
ã¢ã»ããã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20
âãžãªã³ã®æº¶æ¶²ã«ãããªã¹ïŒããªããšãã«ãã¹
ãã€ã³ããžãŠã ïŒïŒïŒâã¯ããªã15ïœãçšã
ãŠã宀枩ã§ãæšæºå§äžã«20æéæ°ŽçŽ æ·»å ãæœ
ããç空ã§èžçºä¹Ÿåºããã€ç²çæç©ã«ãçªé žã²
ã«ã«ããã¡ãã¬ã³ã¯ããªãâã¢ã»ãã³åŸé ïŒïŒ
ã15ïŒ ã¢ã»ãã³ïŒãçšããŠã¯ãããã°ã©ãã€ãŒ
ãæœããåéïŒ21âã¢ã»ããã·âïŒâãã«ãªã«
â17âããããã·â16αâã¡ãã«â11βâããª
ãã«ãªã«ã¢ã»ããã·âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³24.8ïœãèç¹248ã250â (b) ã¯ãããã«ã 150mlåã³ã¡ãã©ãŒã«150mläžã®
é ¢é žãããªãŠã ïŒïœã®æžæ¿æ¶²ã«ã21âã¢ã»ãã
ã·âïŒâãã«ãªã«â17âããããã·â16αâã¡
ãã«â11βâããªãã«ãªã«ã¢ã»ããã·âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒïœãå ãããªãã·
å¡©åç19mlã®æ»Žå åŸã«ã济枩床180âã§ïŒæé
æ¹æãããåå¿æº¶æ¶²ã飜åãœãŒã溶液ã§äžå
ããææ©çžãåé¢ããã€æ°Žã§æŽæµããã也ç¥å
ã³èžçºæ¿çž®åŸã«ç²çæç©ããçªé žã²ã«ã«ããã
ããµã³âé ¢é žãšã¹ãã«åŸé ïŒïŒã50ïŒ é ¢é žãšã¹
ãã«ïŒãçšããŠç²Ÿè£œããã21âã¢ã»ããã·â17
âããããã·â16αâã¡ãã«âïŒâã¡ãã¬ã³â
11βâããªãã«ãªã«ã¢ã»ããã·âïŒâãã¬ã°ã
ã³âïŒïŒ20âãžãªã³ïŒèç¹217ã219âïŒ2.9ïœ
ãåé¢ãããã
mläžã®21âã¢ã»ããã·âïŒâãã«ãªã«â17âã
ãããã·â16αâã¡ãã«â11βâããªãã«ãªã«
ã¢ã»ããã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20
âãžãªã³ã®æº¶æ¶²ã«ãããªã¹ïŒããªããšãã«ãã¹
ãã€ã³ããžãŠã ïŒïŒïŒâã¯ããªã15ïœãçšã
ãŠã宀枩ã§ãæšæºå§äžã«20æéæ°ŽçŽ æ·»å ãæœ
ããç空ã§èžçºä¹Ÿåºããã€ç²çæç©ã«ãçªé žã²
ã«ã«ããã¡ãã¬ã³ã¯ããªãâã¢ã»ãã³åŸé ïŒïŒ
ã15ïŒ ã¢ã»ãã³ïŒãçšããŠã¯ãããã°ã©ãã€ãŒ
ãæœããåéïŒ21âã¢ã»ããã·âïŒâãã«ãªã«
â17âããããã·â16αâã¡ãã«â11βâããª
ãã«ãªã«ã¢ã»ããã·âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³24.8ïœãèç¹248ã250â (b) ã¯ãããã«ã 150mlåã³ã¡ãã©ãŒã«150mläžã®
é ¢é žãããªãŠã ïŒïœã®æžæ¿æ¶²ã«ã21âã¢ã»ãã
ã·âïŒâãã«ãªã«â17âããããã·â16αâã¡
ãã«â11βâããªãã«ãªã«ã¢ã»ããã·âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒïœãå ãããªãã·
å¡©åç19mlã®æ»Žå åŸã«ã济枩床180âã§ïŒæé
æ¹æãããåå¿æº¶æ¶²ã飜åãœãŒã溶液ã§äžå
ããææ©çžãåé¢ããã€æ°Žã§æŽæµããã也ç¥å
ã³èžçºæ¿çž®åŸã«ç²çæç©ããçªé žã²ã«ã«ããã
ããµã³âé ¢é žãšã¹ãã«åŸé ïŒïŒã50ïŒ é ¢é žãšã¹
ãã«ïŒãçšããŠç²Ÿè£œããã21âã¢ã»ããã·â17
âããããã·â16αâã¡ãã«âïŒâã¡ãã¬ã³â
11βâããªãã«ãªã«ã¢ã»ããã·âïŒâãã¬ã°ã
ã³âïŒïŒ20âãžãªã³ïŒèç¹217ã219âïŒ2.9ïœ
ãåé¢ãããã
(c) 21âã¢ã»ããã·â17âããããã·â16αâã¡
ãã«âïŒâã¡ãã¬ã³â11βâããªãã«ãªã«ã¢ã»
ããã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³15ïœ
ããã¡ã¿ããŒã«225mlåã³ããªãšãã«ã¢ãã³15
mläžã«æº¶ããã宀枩ã§20åæ¹æããç空ã§èžçº
æ¿çž®ããã€ã¢ã»ãã³ïŒãããµã³ããåçµæ¶ãã
ããåéïŒ21âã¢ã»ããã·âïŒâãã«ãªã«â
11βïŒ17âãžããããã·â16αâã¡ãã«âïŒâ
ã¡ãã¬ã³âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
ïŒèç¹187ã189âïŒ12.4ïœã
ãã«âïŒâã¡ãã¬ã³â11βâããªãã«ãªã«ã¢ã»
ããã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³15ïœ
ããã¡ã¿ããŒã«225mlåã³ããªãšãã«ã¢ãã³15
mläžã«æº¶ããã宀枩ã§20åæ¹æããç空ã§èžçº
æ¿çž®ããã€ã¢ã»ãã³ïŒãããµã³ããåçµæ¶ãã
ããåéïŒ21âã¢ã»ããã·âïŒâãã«ãªã«â
11βïŒ17âãžããããã·â16αâã¡ãã«âïŒâ
ã¡ãã¬ã³âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
ïŒèç¹187ã189âïŒ12.4ïœã
(d) 21âã¢ã»ããã·âïŒâãã«ãªã«â11βïŒ17â
ãžããããã·â16αâã¡ãã«âïŒâã¡ãã¬ã³â
ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³12ïœãå ç±äž
ã«ã€ãœãããããŒã«620mläžã«æº¶ãããã€ãã©
ãžãŠã ïŒççŽ ïŒ9.5ïŒ ïŒ2.6ïœåã³ã·ã¯ãããã»
ã³36mlã®æ·»å åŸã«æµŽæž©åºŠ110âã§ïŒæéæ¹æã
ãã次ã«ããã«è§ŠåªïŒïœåã³ã·ã¯ãããã»ã³36
mlãå ãããåŒç¶ã20æéæ¹æããåå¿æº¶æ¶²ã
ã»ã©ã€ãïŒCeliteïŒã«ããåžåŒæ¿Ÿéãã次ã«å¡©
åã¡ãã³ãçšããŠååã«æŽæµããã€ç空ã§èžçº
也åºãããç²çæç©ãçªé žã²ã«ã«ãããããµã³
âé ¢é žãšã¹ãã«åŸé ïŒïŒã80ïŒ é ¢é žãšã¹ãã«ïŒ
ãçšããŠç²Ÿè£œããã21âã¢ã»ããã·âïŒâãã«
ãªã«â11βïŒ17âãžããããã·â6αïŒ16αâãž
ã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒè
ç¹204ã205âïŒ7.8ïœãåé¢ãããã
ãžããããã·â16αâã¡ãã«âïŒâã¡ãã¬ã³â
ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³12ïœãå ç±äž
ã«ã€ãœãããããŒã«620mläžã«æº¶ãããã€ãã©
ãžãŠã ïŒççŽ ïŒ9.5ïŒ ïŒ2.6ïœåã³ã·ã¯ãããã»
ã³36mlã®æ·»å åŸã«æµŽæž©åºŠ110âã§ïŒæéæ¹æã
ãã次ã«ããã«è§ŠåªïŒïœåã³ã·ã¯ãããã»ã³36
mlãå ãããåŒç¶ã20æéæ¹æããåå¿æº¶æ¶²ã
ã»ã©ã€ãïŒCeliteïŒã«ããåžåŒæ¿Ÿéãã次ã«å¡©
åã¡ãã³ãçšããŠååã«æŽæµããã€ç空ã§èžçº
也åºãããç²çæç©ãçªé žã²ã«ã«ãããããµã³
âé ¢é žãšã¹ãã«åŸé ïŒïŒã80ïŒ é ¢é žãšã¹ãã«ïŒ
ãçšããŠç²Ÿè£œããã21âã¢ã»ããã·âïŒâãã«
ãªã«â11βïŒ17âãžããããã·â6αïŒ16αâãž
ã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒè
ç¹204ã205âïŒ7.8ïœãåé¢ãããã
(e) ã¡ã¿ããŒã«260mlåã³æ°Ž26mläžã®21âã¢ã»ã
ãã·âïŒâãã«ãªã«â11βïŒ17âãžããããã·
â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³5.2ïœã®æº¶æ¶²ããã¢ã«ãŽã³äžã«çé ž
ã«ã«ã·ãŠã 1.3ïœãšå ±ã«å®€æž©ã§45åéæ¹æããã
æ°·æ°Žæ²æ®¿åŸã«åžåŒæ¿Ÿéããéåžžã®ããã«åŸåžç
ãããïŒâãã«ãªã«â11βïŒ17ïŒ21âããªãã
ããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³ïŒèç¹242ã243âïŒ4.5ïœã
åé¢ãããã
ãã·âïŒâãã«ãªã«â11βïŒ17âãžããããã·
â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³5.2ïœã®æº¶æ¶²ããã¢ã«ãŽã³äžã«çé ž
ã«ã«ã·ãŠã 1.3ïœãšå ±ã«å®€æž©ã§45åéæ¹æããã
æ°·æ°Žæ²æ®¿åŸã«åžåŒæ¿Ÿéããéåžžã®ããã«åŸåžç
ãããïŒâãã«ãªã«â11βïŒ17ïŒ21âããªãã
ããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³ïŒèç¹242ã243âïŒ4.5ïœã
åé¢ãããã
(f) ãžã¡ãã«ãã«ã ã¢ããïŒmlåã³ãããµã³ïŒã·
ã¯ããããµã³ïŒ60mläžã®ïŒâãã«ãªã«â11βïŒ
17ïŒ21âããªããããã·â6αïŒ16αâãžã¡ãã«
âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³800mgåã³
ããªãžããŠã ãã·ã¬ãŒã80mgããæãæ··æ¿æ··å
ç©ããã济枩床130âã§æº¶å€çŽ24mlãçå»ããã
çæéã®å·åŽåŸã«ç±æº¶æ¶²äžã«ãªã«ãé ¢é žããªãš
ãã«ãšã¹ãã«ïŒmlãå ããæ®ãã®ãããµã³ïŒã·
ã¯ããããµã³ïŒãçå»ãããæåŸã«è©²æº¶æ¶²ã«ã
ãªãžã³0.8mlãå ãã60âã§ç空èžçºããã17ïŒ
21âïŒïŒâãšããã·âãšããªãã³ïŒâïŒâãã«ãª
ã«â11βâããããã·â6αïŒ16αâãžã¡ãã«â
ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ãæ²¹ç¶ç©ãšã
ãŠåŸãããã
ã¯ããããµã³ïŒ60mläžã®ïŒâãã«ãªã«â11βïŒ
17ïŒ21âããªããããã·â6αïŒ16αâãžã¡ãã«
âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³800mgåã³
ããªãžããŠã ãã·ã¬ãŒã80mgããæãæ··æ¿æ··å
ç©ããã济枩床130âã§æº¶å€çŽ24mlãçå»ããã
çæéã®å·åŽåŸã«ç±æº¶æ¶²äžã«ãªã«ãé ¢é žããªãš
ãã«ãšã¹ãã«ïŒmlãå ããæ®ãã®ãããµã³ïŒã·
ã¯ããããµã³ïŒãçå»ãããæåŸã«è©²æº¶æ¶²ã«ã
ãªãžã³0.8mlãå ãã60âã§ç空èžçºããã17ïŒ
21âïŒïŒâãšããã·âãšããªãã³ïŒâïŒâãã«ãª
ã«â11βâããããã·â6αïŒ16αâãžã¡ãã«â
ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ãæ²¹ç¶ç©ãšã
ãŠåŸãããã
(g) ã¡ã¿ããŒã«24mläžã®ç²è£œ17ïŒ21âïŒïŒâãšã
ãã·âãšããªãã³ïŒâïŒâãã«ãªã«â11βâã
ãããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ã
ã³âïŒïŒ20âãžãªã³ã®æžæ¿æ¶²ãã0.1molé ¢é ž
ãããªãŠã æ°Žæ§æº¶æ¶²0.96mlåã³0.1Næ°Žæ§é ¢é ž
8.5mlããæãæ··åç©ãšå ±ã«100âã§ïŒæééæµ
ããããæ··æ¿ãããŸã§èžçºæ¿çž®ããæ°Žäžã«æ³šã
ãã€é ¢é žãšã¹ãã«ãçšããŠæœåºãè¡ããææ©çž
ãæ°Žã§æŽæµããç¡«é žãããªãŠã ã«ãã也ç¥ãã
ç空ã§èžçºä¹Ÿåºãããç²çæç©ãçªé žã²ã«65ïœ
ã«ãããããµã³âã¢ã»ãã³åŸé ïŒïŒã50ïŒ ã¢ã»
ãã³ïŒãçšããŠç²Ÿè£œãããåéïŒ17âã¢ã»ãã
ã·âïŒâãã«ãªã«â11βïŒ21âããããã·â
6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³ïŒèç¹210ã211âïŒ798mgã
ãã·âãšããªãã³ïŒâïŒâãã«ãªã«â11βâã
ãããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ã
ã³âïŒïŒ20âãžãªã³ã®æžæ¿æ¶²ãã0.1molé ¢é ž
ãããªãŠã æ°Žæ§æº¶æ¶²0.96mlåã³0.1Næ°Žæ§é ¢é ž
8.5mlããæãæ··åç©ãšå ±ã«100âã§ïŒæééæµ
ããããæ··æ¿ãããŸã§èžçºæ¿çž®ããæ°Žäžã«æ³šã
ãã€é ¢é žãšã¹ãã«ãçšããŠæœåºãè¡ããææ©çž
ãæ°Žã§æŽæµããç¡«é žãããªãŠã ã«ãã也ç¥ãã
ç空ã§èžçºä¹Ÿåºãããç²çæç©ãçªé žã²ã«65ïœ
ã«ãããããµã³âã¢ã»ãã³åŸé ïŒïŒã50ïŒ ã¢ã»
ãã³ïŒãçšããŠç²Ÿè£œãããåéïŒ17âã¢ã»ãã
ã·âïŒâãã«ãªã«â11βïŒ21âããããã·â
6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³ïŒèç¹210ã211âïŒ798mgã
äŸ ïŒ
ããªãžã³6.5mlåã³ç¡æ°Žé
¢é
ž3.2mläžã®17âã¢ã»
ããã·âïŒâãã«ãªã«â11βïŒ21âãžããããã·
â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³650mgã®æº¶æ¶²ã宀枩ã§ïŒæéæ¹æããæ°·
æ°Žâé£å¡©æº¶æ¶²äžã«æ³šããæ¿Ÿå¥ããŠãåžžæ³ã§åŸåŠç
ããããããµã³ïŒé ¢é žãšã¹ãã«ããçµæ¶åŸã«17ïŒ
21âãžã¢ã»ããã·âïŒâãã«ãªã«â11βâããã
ãã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³ïŒèç¹194ã195âïŒ430mgãåé¢
ãããã
ããã·âïŒâãã«ãªã«â11βïŒ21âãžããããã·
â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³650mgã®æº¶æ¶²ã宀枩ã§ïŒæéæ¹æããæ°·
æ°Žâé£å¡©æº¶æ¶²äžã«æ³šããæ¿Ÿå¥ããŠãåžžæ³ã§åŸåŠç
ããããããµã³ïŒé ¢é žãšã¹ãã«ããçµæ¶åŸã«17ïŒ
21âãžã¢ã»ããã·âïŒâãã«ãªã«â11βâããã
ãã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³ïŒèç¹194ã195âïŒ430mgãåé¢
ãããã
äŸ ïŒ
(a) ïŒâãã«ãªã«â11βïŒ17ïŒ21âããªãããã
ã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³500mgããäŸ1fãšåæ§ã«ããŠãª
ã«ãããããªã³é žããªãšãã«ãšã¹ãã«1.2mlãš
åå¿ãããŠã17ïŒ21âïŒïŒâãšããã·âããã
ãªãã³âãžãªãã·ïŒâïŒâãã«ãªã«â11βâã
ãããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ã
ã³âïŒïŒ20âãžãªã³ãçæãããã
ã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³500mgããäŸ1fãšåæ§ã«ããŠãª
ã«ãããããªã³é žããªãšãã«ãšã¹ãã«1.2mlãš
åå¿ãããŠã17ïŒ21âïŒïŒâãšããã·âããã
ãªãã³âãžãªãã·ïŒâïŒâãã«ãªã«â11βâã
ãããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ã
ã³âïŒïŒ20âãžãªã³ãçæãããã
(b) ç²è£œ17ïŒ21âïŒïŒâãšããã·âããããªãã³
ãžãªãã·ïŒâïŒâãã«ãªã«â11βâããããã·
â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ
20ããäŸïŒïœã®æ¡ä»¶äžãŠæ°ŽçŽ æ·»å ããåŸåŠçã
ãŠç²Ÿè£œãããïŒâãã«ãªã«â11βïŒ21âãžãã
ããã·â6αïŒ16αâãžã¡ãã«â17âããããªã
ã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
ïŒèç¹195ã196âïŒ439mgãåé¢ãããã
ãžãªãã·ïŒâïŒâãã«ãªã«â11βâããããã·
â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ
20ããäŸïŒïœã®æ¡ä»¶äžãŠæ°ŽçŽ æ·»å ããåŸåŠçã
ãŠç²Ÿè£œãããïŒâãã«ãªã«â11βïŒ21âãžãã
ããã·â6αïŒ16αâãžã¡ãã«â17âããããªã
ã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
ïŒèç¹195ã196âïŒ439mgãåé¢ãããã
äŸ ïŒ
äŸïŒã®ããã«ããŠãïŒâãã«ãªã«â11βïŒ21â
ãžããããã·â6αïŒ16αâãžã¡ãã«â17âããã
ãªãã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
400mgãç¡æ°Žé ¢é žãšåå¿ãããŠã21âã¢ã»ããã·
âïŒâãã«ãªã«â11βâããããã·â6αïŒ16αâ
ãžã¡ãã«â17âããããªãã«ãªãã·âïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³312ïœãçæããããèç¹
196ã198âã
ãžããããã·â6αïŒ16αâãžã¡ãã«â17âããã
ãªãã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
400mgãç¡æ°Žé ¢é žãšåå¿ãããŠã21âã¢ã»ããã·
âïŒâãã«ãªã«â11βâããããã·â6αïŒ16αâ
ãžã¡ãã«â17âããããªãã«ãªãã·âïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³312ïœãçæããããèç¹
196ã198âã
äŸ ïŒ
ãžã¡ãã«ãã«ã ã¢ãã25mläžã®17ïŒ21âïŒïŒâ
ãšããã·âããããªãã³ãžãªãã·ïŒâïŒâãã«ãª
ã«â11βâããããã·â6αïŒ16αâãžã¡ãã«âïŒ
âãã¬ã°ãã³âïŒïŒ20âãžãªã³ã500mgã®æº¶æ¶²ãã
ããªã¡ãã«ã¯ãã«ã·ã©ã³ïŒmlã®æ»Žå åŸã«ã济枩床
80âã§23æéæ¹æãããæ°·æ°Žæ²æ®¿åã³åžžæ³ã«ãã
åŸåŠçåŸã«ç²çæç©ããçªé žã²ã«ã«ãããããµã³
âã¢ã»ãã³åŸé ïŒïŒã30ã¢ã»ãã³ïŒãçšããŠç²Ÿè£œ
ãããåéïŒ21âã¯ãã«âïŒâãã«ãªã«â11βâ
ããããã·â6αïŒ16αâãžã¡ãã«â17âããããª
ãã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
ïŒèç¹258ã260âïŒ246mgã
ãšããã·âããããªãã³ãžãªãã·ïŒâïŒâãã«ãª
ã«â11βâããããã·â6αïŒ16αâãžã¡ãã«âïŒ
âãã¬ã°ãã³âïŒïŒ20âãžãªã³ã500mgã®æº¶æ¶²ãã
ããªã¡ãã«ã¯ãã«ã·ã©ã³ïŒmlã®æ»Žå åŸã«ã济枩床
80âã§23æéæ¹æãããæ°·æ°Žæ²æ®¿åã³åžžæ³ã«ãã
åŸåŠçåŸã«ç²çæç©ããçªé žã²ã«ã«ãããããµã³
âã¢ã»ãã³åŸé ïŒïŒã30ã¢ã»ãã³ïŒãçšããŠç²Ÿè£œ
ãããåéïŒ21âã¯ãã«âïŒâãã«ãªã«â11βâ
ããããã·â6αïŒ16αâãžã¡ãã«â17âããããª
ãã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
ïŒèç¹258ã260âïŒ246mgã
äŸ ïŒ
(a) äŸ1fã®æ¡ä»¶äžã§11βïŒ17ïŒ21âããªãããã
ã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³1.0ïœããªã«ãããããªã³é žãš
ãã«ãšã¹ãã«ãšåå¿ãããŠã17ïŒ21âïŒïŒâãš
ããã·âããããªãã³ãžãªãã·ïŒâ11βâãã
ããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³ãçæãããã
ã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³1.0ïœããªã«ãããããªã³é žãš
ãã«ãšã¹ãã«ãšåå¿ãããŠã17ïŒ21âïŒïŒâãš
ããã·âããããªãã³ãžãªãã·ïŒâ11βâãã
ããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³ãçæãããã
(b) ç²è£œ17ïŒ21âïŒïŒâãšããã·âããããªãã³
ãžãªãã·ïŒâ11βâããããã·â6αïŒ16αâãžã¡
ãã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ããäŸ
ïŒïœã«åŸã€ãŠæ°ŽçŽ æ·»å ããåŸåŠçããã€ç²Ÿè£œã
ãã11βïŒ21âãžããããã·â6αïŒ16αâãžã¡
ãã«â17âããããªãã«ãªãã·âïŒâãã¬ã°ã
ã³âïŒïŒ20âãžãªã³782mgãåé¢ãããã
ãžãªãã·ïŒâ11βâããããã·â6αïŒ16αâãžã¡
ãã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ããäŸ
ïŒïœã«åŸã€ãŠæ°ŽçŽ æ·»å ããåŸåŠçããã€ç²Ÿè£œã
ãã11βïŒ21âãžããããã·â6αïŒ16αâãžã¡
ãã«â17âããããªãã«ãªãã·âïŒâãã¬ã°ã
ã³âïŒïŒ20âãžãªã³782mgãåé¢ãããã
(c) äŸïŒã§èšèŒããããã«ããŠã11βïŒ21âãžã
ãããã·â6αïŒ16αâãžã¡ãã«â17âããããª
ãã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
500mgããç¡æ°Žé ¢é žãšåå¿ãããåŸåŠçããã€
粟補ããã21âã¢ã»ããã·â11βâããããã·
â6αïŒ16αâãžã¡ãã«â17âããããªãã«ãªã
ã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒèç¹
168ã170âïŒ396mgãåŸãããã
ãããã·â6αïŒ16αâãžã¡ãã«â17âããããª
ãã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
500mgããç¡æ°Žé ¢é žãšåå¿ãããåŸåŠçããã€
粟補ããã21âã¢ã»ããã·â11βâããããã·
â6αïŒ16αâãžã¡ãã«â17âããããªãã«ãªã
ã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒèç¹
168ã170âïŒ396mgãåŸãããã
äŸ ïŒ
ãžãªããµã³100mläžã®21âã¢ã»ããã·â11βâ
ããããã·â6αïŒ16αâãžã¡ãã«â17âããããª
ãã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
2.0ïœã®æº¶æ¶²ãããžã¯ãããžã·ã¢ããã³ãŸããã³
2.0ïœãšå ±ã«éæµäžã«24æéç ®æ²žãããå·åŽåŸã«
åºäœãåžåŒæ¿Ÿåãããããµã³ã§æŽæµãã濟液ãç
空ã§èžçºæ¿çž®ãããç²è£œçæç©ãçªé žã²ã«ã«ãã
ãããµã³âã¢ã»ãã³åŸé ïŒïŒã40ïŒ ã¢ã»ãã³ïŒã
çšããŠç²Ÿè£œããã21âã¢ã»ããã·â11βâããã
ãã·â6αïŒ16αâãžã¡ãã«â17âããããªãã«ãª
ãã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
ïŒèç¹182ã184âïŒãåé¢ãããã
ããããã·â6αïŒ16αâãžã¡ãã«â17âããããª
ãã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
2.0ïœã®æº¶æ¶²ãããžã¯ãããžã·ã¢ããã³ãŸããã³
2.0ïœãšå ±ã«éæµäžã«24æéç ®æ²žãããå·åŽåŸã«
åºäœãåžåŒæ¿Ÿåãããããµã³ã§æŽæµãã濟液ãç
空ã§èžçºæ¿çž®ãããç²è£œçæç©ãçªé žã²ã«ã«ãã
ãããµã³âã¢ã»ãã³åŸé ïŒïŒã40ïŒ ã¢ã»ãã³ïŒã
çšããŠç²Ÿè£œããã21âã¢ã»ããã·â11βâããã
ãã·â6αïŒ16αâãžã¡ãã«â17âããããªãã«ãª
ãã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
ïŒèç¹182ã184âïŒãåé¢ãããã
äŸ ïŒ
(a) ïŒâãã«ãªã«â11βïŒ17ïŒ21âããªãããã
ã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³2.5ïœåã³ããªãžããŠã ãã«ãª
ãŒã«ã¹ã«ãããŒã250mgããã¢ã«ãŽã³äžã«ã¡ã
ã«âïœâããã«ãšãŒãã«ãããªããã³
ïŒDriveronïŒïŒ³ã100mläžã§æžæ¿ãããå éšæž©
床58âã§ããªããã³S25mlãçå»ãããããã
40âã«å·åŽãããªã«ãé ªé žããªãšãã«ãšã¹ãã«
ïŒmlãå ãã次ã«éæµäžã«2.5æéç ®æ²žããã
溶解ããªãæåã¯ååšããŠããªããããªãžã³ïŒ
mlãå ãã溶液ãèžçºæ¿çž®ãããšã17ïŒ21â
ïŒïŒâãšããã·ãããªãã³ãžãªãã·ïŒâïŒâãã«
ãªã«â11βâããããã·â6αïŒ16αâãžã¡ãã«
âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ãæ²¹ç¶ç©ãš
ããŠçæãããã
ã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³2.5ïœåã³ããªãžããŠã ãã«ãª
ãŒã«ã¹ã«ãããŒã250mgããã¢ã«ãŽã³äžã«ã¡ã
ã«âïœâããã«ãšãŒãã«ãããªããã³
ïŒDriveronïŒïŒ³ã100mläžã§æžæ¿ãããå éšæž©
床58âã§ããªããã³S25mlãçå»ãããããã
40âã«å·åŽãããªã«ãé ªé žããªãšãã«ãšã¹ãã«
ïŒmlãå ãã次ã«éæµäžã«2.5æéç ®æ²žããã
溶解ããªãæåã¯ååšããŠããªããããªãžã³ïŒ
mlãå ãã溶液ãèžçºæ¿çž®ãããšã17ïŒ21â
ïŒïŒâãšããã·ãããªãã³ãžãªãã·ïŒâïŒâãã«
ãªã«â11βâããããã·â6αïŒ16αâãžã¡ãã«
âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ãæ²¹ç¶ç©ãš
ããŠçæãããã
(b) ç²è£œâ17ïŒ21âïŒïŒâãšããã·ãããªãã³ãž
ãªãã·ïŒâïŒâãã«ãªã«â11βâããããã·â
6αïŒ16αâãžã¡ãã«âïŒâãã«ã°ãã³âïŒïŒ20
âãžãªã³ããäŸïŒïœã®æ¡ä»¶äžã§å æ°Žå解ããŠ17
âãããªã«ãªãã·âïŒâãã«ãªã«â11βïŒ21â
ãžããããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬
ã°ãã³âïŒïŒ20âãžãªã³ãçæããåŸåŠçãã
ã€ç²Ÿè£œãããèç¹166ã167âã
ãªãã·ïŒâïŒâãã«ãªã«â11βâããããã·â
6αïŒ16αâãžã¡ãã«âïŒâãã«ã°ãã³âïŒïŒ20
âãžãªã³ããäŸïŒïœã®æ¡ä»¶äžã§å æ°Žå解ããŠ17
âãããªã«ãªãã·âïŒâãã«ãªã«â11βïŒ21â
ãžããããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬
ã°ãã³âïŒïŒ20âãžãªã³ãçæããåŸåŠçãã
ã€ç²Ÿè£œãããèç¹166ã167âã
äŸ ïŒ
äŸïŒã§èšèŒããããã«ããŠãããªãžã³äžã®17â
ãããªã«ãªãã·âïŒâãã«ãªã«â11βïŒ21âãžã
ãããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³2.4ïœããç¡æ°Žé ¢é ž12mlãšåå¿
ãããåŸåŠçããã€ç²Ÿè£œãããåéïŒ21âã¢ã»ã
ãã·â17âãããªã«ãªãã·âïŒâãã«ãªã«â11β
âããããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³2.6ïœãèç¹181ã182âã
ãããªã«ãªãã·âïŒâãã«ãªã«â11βïŒ21âãžã
ãããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³2.4ïœããç¡æ°Žé ¢é ž12mlãšåå¿
ãããåŸåŠçããã€ç²Ÿè£œãããåéïŒ21âã¢ã»ã
ãã·â17âãããªã«ãªãã·âïŒâãã«ãªã«â11β
âããããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³2.6ïœãèç¹181ã182âã
äŸ 10
äŸïŒã®ããã«ããŠã21âã¢ã»ããã·â17âãã
ãªã«ãªãã·âïŒâãã«ãªã«â11βâããããã·â
6αïŒ16αâãžã¡ãã«âïŒâãã«ã°ãã³âïŒïŒ20â
ãžãªã³2.0ïœãããžã¯ãããžã·ã¢ããã³ãŸããã³
2.0ïœãçšããŠè±æ°ŽçŽ ããåŸåŠçããã€ç²Ÿè£œããã
21âã¢ã»ããã·â17âãããªã«ãªãã·âïŒâãã«
ãªã«â11βâããããã·â6αïŒ16αâãžã¡ãã«â
ïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ïŒèç¹
229ã230âïŒ940mgãåé¢ãããã
ãªã«ãªãã·âïŒâãã«ãªã«â11βâããããã·â
6αïŒ16αâãžã¡ãã«âïŒâãã«ã°ãã³âïŒïŒ20â
ãžãªã³2.0ïœãããžã¯ãããžã·ã¢ããã³ãŸããã³
2.0ïœãçšããŠè±æ°ŽçŽ ããåŸåŠçããã€ç²Ÿè£œããã
21âã¢ã»ããã·â17âãããªã«ãªãã·âïŒâãã«
ãªã«â11βâããããã·â6αïŒ16αâãžã¡ãã«â
ïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ïŒèç¹
229ã230âïŒ940mgãåé¢ãããã
äŸ 11
(a) äŸ1aã®æ¡ä»¶äžã§ãïŒâãã«ãªã«â11βïŒ17ïŒ
21âããªããããã·â6αïŒ16αâãžã¡ãã«âïŒ
âãã«ã°ãã³âïŒïŒ20âãžãªã³1.4ïœãããªã«
ãå®æ¯éŠé žããªãšãã«ãšã¹ãã«3.4mlãšåå¿ã
ããŠã17ïŒ21âïŒïŒâãšããã·âãã³ãžãªãã³
ãžãªãã·ïŒâïŒâãã«ãªã«â11βâããããã·
â6αïŒ16αâãžã¡ãã«âïŒâãã«ã°ãã³âïŒïŒ
20âãžãªã³ãæ²¹ç¶ç©ãšããŠåŸãã
21âããªããããã·â6αïŒ16αâãžã¡ãã«âïŒ
âãã«ã°ãã³âïŒïŒ20âãžãªã³1.4ïœãããªã«
ãå®æ¯éŠé žããªãšãã«ãšã¹ãã«3.4mlãšåå¿ã
ããŠã17ïŒ21âïŒïŒâãšããã·âãã³ãžãªãã³
ãžãªãã·ïŒâïŒâãã«ãªã«â11βâããããã·
â6αïŒ16αâãžã¡ãã«âïŒâãã«ã°ãã³âïŒïŒ
20âãžãªã³ãæ²¹ç¶ç©ãšããŠåŸãã
(b) ç²è£œ17ïŒ21âïŒïŒâãšããã·âãã³ãžãªãã³
ãžãªãã·ïŒâïŒâãã«ãªã«â11βâããããã·
â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³ããäŸïŒïœã®æ¡ä»¶äžã§å æ°Žå解ãã
åŸåŠçããã€ç²Ÿè£œããã17âãã³ãŸã€ã«ãªãã·
âïŒâãã«ãªã«â11βïŒ21âãžããããã·â
6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³140mgã泡ç¶ç©ãšããŠåé¢ãããã
ãžãªãã·ïŒâïŒâãã«ãªã«â11βâããããã·
â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³ããäŸïŒïœã®æ¡ä»¶äžã§å æ°Žå解ãã
åŸåŠçããã€ç²Ÿè£œããã17âãã³ãŸã€ã«ãªãã·
âïŒâãã«ãªã«â11βïŒ21âãžããããã·â
6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³140mgã泡ç¶ç©ãšããŠåé¢ãããã
äŸ 12
(a) ããªãžã³ïŒmläžã®17âãããªã«ãªãã·âïŒâ
ãã«ãªã«â11βïŒ21âãžããããã·â6αïŒ16α
âãžã¡ãã«âïŒâãã«ã°ãã³âïŒïŒ20âãžãªã³
2.0ïœã®æº¶æ¶²ã«ãïŒâã§ã¡ã¿ã³ã¹ã«ãã³é žã¯ã
ãªãïŒmlã滎å ãããåŒç¶ãïŒâã§ïŒæéæ¹æ
ããæ°·æ°Žâé£å¡©æº¶æ¶²äžã«æ³šããåžžæ³ã§åŸåŠçã
ãã17âãããªã«ãªãã·âïŒâãã«ãªã«â11β
âããããã·â21âã¡ã·ã«ãªãã·â6αïŒ16αâ
ãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
1.9ïœãåé¢ãããã
ãã«ãªã«â11βïŒ21âãžããããã·â6αïŒ16α
âãžã¡ãã«âïŒâãã«ã°ãã³âïŒïŒ20âãžãªã³
2.0ïœã®æº¶æ¶²ã«ãïŒâã§ã¡ã¿ã³ã¹ã«ãã³é žã¯ã
ãªãïŒmlã滎å ãããåŒç¶ãïŒâã§ïŒæéæ¹æ
ããæ°·æ°Žâé£å¡©æº¶æ¶²äžã«æ³šããåžžæ³ã§åŸåŠçã
ãã17âãããªã«ãªãã·âïŒâãã«ãªã«â11β
âããããã·â21âã¡ã·ã«ãªãã·â6αïŒ16αâ
ãžã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
1.9ïœãåé¢ãããã
(b) âã¡ãã«ãããªãã³40mläžã®17âãããªã«
ãªãã·âïŒâãã«ãªã«â11βâããããã·â21
âã¡ã·ã«ãªãã·â6αïŒ16αâãžã¡ãã«âïŒâã
ã«ã°ãã³âïŒïŒ20âãžãªã³1.9ïœåã³èåãªã
ãŠã 1.9ïœã®æžæ¿æ¶²ãã济枩床80âã§ïŒæéæ¹
æããåžžæ³ã§åŸåŠçãããçªé žã²ã«ã«ãããã
ãµã³âã¢ã»ãã³åŸé ïŒïŒã30ïŒ ã¢ã»ãã³ïŒãçš
ããŠã¯ãããã°ã©ãã€ãŒãæœããåŸã21âãã
ã â17âãããªã«ãªãã·âïŒâãã«ãªã«â11β
âããããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬
ã°ãã³âïŒïŒ20âãžãªã³1.2ïœãåé¢ãããã
ãªãã·âïŒâãã«ãªã«â11βâããããã·â21
âã¡ã·ã«ãªãã·â6αïŒ16αâãžã¡ãã«âïŒâã
ã«ã°ãã³âïŒïŒ20âãžãªã³1.9ïœåã³èåãªã
ãŠã 1.9ïœã®æžæ¿æ¶²ãã济枩床80âã§ïŒæéæ¹
æããåžžæ³ã§åŸåŠçãããçªé žã²ã«ã«ãããã
ãµã³âã¢ã»ãã³åŸé ïŒïŒã30ïŒ ã¢ã»ãã³ïŒãçš
ããŠã¯ãããã°ã©ãã€ãŒãæœããåŸã21âãã
ã â17âãããªã«ãªãã·âïŒâãã«ãªã«â11β
âããããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬
ã°ãã³âïŒïŒ20âãžãªã³1.2ïœãåé¢ãããã
(c) ããã©ããããã©ã³30mläžã®21âããã â17
âãããªã«ãªãã·âïŒâãã«ãªã«â11βâãã
ããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³1.2ïœããããªããã«é«æ°ŽçŽ
åç©7.5mlåã³Î±ïŒÎ±â²âã¢ãŸãã¹ïŒã€ãœããã
ãããªã«ïŒïŒã¹ãããŠã©ãšå ±ã«ã济枩床50âã§
ïŒæéæ¹æããã次ã«ç空ã§èžçºæ¿çž®ããæ®ç
ç©ã«ãããµã³âã¢ã»ãã³åŸé ïŒïŒã25ïŒ ã¢ã»ã
ã³ïŒãçšããŠã¯ãããã°ã©ãã€ãŒãæœãã17â
ãããªã«ãªãã·âïŒâãã«ãªã«â11βâããã
ãã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³920mgãåé¢ãããã
âãããªã«ãªãã·âïŒâãã«ãªã«â11βâãã
ããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³1.2ïœããããªããã«é«æ°ŽçŽ
åç©7.5mlåã³Î±ïŒÎ±â²âã¢ãŸãã¹ïŒã€ãœããã
ãããªã«ïŒïŒã¹ãããŠã©ãšå ±ã«ã济枩床50âã§
ïŒæéæ¹æããã次ã«ç空ã§èžçºæ¿çž®ããæ®ç
ç©ã«ãããµã³âã¢ã»ãã³åŸé ïŒïŒã25ïŒ ã¢ã»ã
ã³ïŒãçšããŠã¯ãããã°ã©ãã€ãŒãæœãã17â
ãããªã«ãªãã·âïŒâãã«ãªã«â11βâããã
ãã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³920mgãåé¢ãããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒïŒ åŒäžçµåæãã¯åçµååã¯äºéçµåãè¡šããã
ã¯æ°ŽçŽ ååãåŒçŽ ååãå¡©çŽ åååã¯èçŽ åå
ãè¡šãããR1ã¯ççŽ ååïŒãïŒåãæããã¢ã«
ã«ãã€ã«åºåã¯ãã³ãŸã€ã«åºãè¡šãããã¯æ°ŽçŽ
ååãå¡©çŽ ååãããããã·åºåã¯ã¢ã»ããã·åº
ãè¡šããã§ç€ºããã6αïŒ16αâãžã¡ãã«ã³ã«ã
ã³ã€ãã ïŒ 17αâã¢ã»ããã·â9αâãã«ãªã«â11βïŒ21
âãžããããã·â6αïŒ16αâãžã¡ãã«âïŒâãã¬
ã°ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®ååç©ã ïŒ 17αïŒ21âãžã¢ã»ããã·â9αâãã«ãªã«â
11βâããããã·â6αïŒ16αâãžã¡ãã«âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²
第ïŒé èšèŒã®ååç©ã ïŒ 9αâãã«ãªã«â11βïŒ21âãžããããã·â
6αïŒ16αâãžã¡ãã«â17αâããããªãã«ãªãã·
âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 21âã¢ã»ããã·â9αâãã«ãªã«â11βâãã
ããã·â6αïŒ16αâãžã¡ãã«â17αâããããªã
ã«ãªãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 21âã¯ãã«â9αâãã«ãªã«â11βâãããã
ã·â6αïŒ16αâãžã¡ãã«â17αâããããªãã«ãª
ãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 21âã¢ã»ããã·â11βâããããã·â6αïŒ
16αâãžã¡ãã«â17αâããããªãã«ãªãã·âïŒ
âãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 21âã¢ã»ããã·â11βâããããã·â6αïŒ
16αâãžã¡ãã«â17αâããããªãã«ãªãã·âïŒïŒ
ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 17αâãããªã«ãªãã·â9αâãã«ãªã«â11βïŒ
21âãžããããã·â6αïŒ16αâãžã¡ãã«âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²
第ïŒé èšèŒã®ååç©ã ïŒïŒ 21âã¢ã»ããã·â17αâãããªã«ãªãã·â
9αâãã«ãªã«â11βâããããã·â6αïŒ16αâãž
ã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 21âã¢ã»ããã·â17αâãããªã«ãªãã·â
9αâãã«ãªã«â11βâããããã·â6αïŒ16αâãž
ã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãª
ã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 17αâãã³ãŸã€ã«ãªãã·â9αâãã«ãªã«â
11βïŒ21âãžããããã·â6αïŒ16αâãžã¡ãã«â
ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 17αâãããªã«ãªãã·â9αâãã«ãªã«â
11βâããããã·â6αïŒ16αâãžã¡ãã«âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²
第ïŒé èšèŒã®ååç©ã ïŒïŒ äžè¬åŒïŒ åŒäžçµåæãã¯åçµååã¯äºéçµåãè¡šããã
ã¯æ°ŽçŽ ååãåŒçŽ ååãå¡©çŽ åååã¯èçŽ åå
ãè¡šãããR1ã¯ççŽ ååïŒãïŒåãæããã¢ã«
ã«ãã€ã«åºåã¯ãã³ãŸã€ã«åºãè¡šãããã¯æ°ŽçŽ
ååãå¡©çŽ ååãããããã·åºåã¯ã¢ã»ããã·åº
ãè¡šããã§ç€ºããã6αïŒ16αâãžã¡ãã«ã³ã«ã
ã³ã€ãã補é ããã«åœããäžè¬åŒïŒ åŒäžããR1åã³ïŒ¹ã¯åèšã®ãã®ãè¡šããã§
瀺ãããã¹ããã€ãã®ãšããã·ãç°ãèªäœå ¬ç¥ã®
æ¹æ³ã§åŒåæ°ŽçŽ ã§éç°ãããã€ææã®å Žåã«ã¯äž
è¬åŒã®ïŒâããã ã¹ããã€ãããïŒäœã«ååšã
ãããã²ã³ååãé€å»ããäžè¬åŒã®ïŒãïŒäœã§
飜åãããã¹ããã€ãããã®äœçœ®ã§è±æ°ŽçŽ ããäž
è¬åŒã®21âã¢ã»ããã·ã¹ããã€ããå æ°Žå解ã
åã¯äžè¬åŒã®21âããããã·ã¹ããã€ãããšã¹
ãã«åããããšãç¹åŸŽãšããåèš6αïŒ16αâãžã¡
ãã«ã³ã«ãã³ã€ãã®è£œé æ³ã ïŒïŒ äžè¬åŒïŒ åŒäžçµåæãã¯åçµååã¯äºéçµåãè¡šããã
ã¯æ°ŽçŽ ååãåŒçŽ ååãå¡©çŽ åååã¯èçŽ åå
ãè¡šãããR1ã¯ççŽ ååïŒãïŒåãæããã¢ã«
ã«ãã€ã«åºåã¯ãã³ãŸã€ã«åºãè¡šãããã¯æ°ŽçŽ
ååãå¡©çŽ ååãããããã·åºåã¯ã¢ã»ããã·åº
ãè¡šããã§ç€ºããã6αïŒ16αâãžã¡ãã«ã³ã«ã
ã³ã€ãã補é ããã«åœããäžè¬åŒïŒ åŒäžããR1åã³ïŒ¹ã¯åèšã®ãã®ãè¡šããã§
瀺ãããã¹ããã€ãã®Î9(11)âäºéçµåã«æ¬¡äºå¡©
çŽ é žåã¯æ¬¡äºèçŽ é žãä»å ãããã€ææã®å Žåã«
ã¯äžè¬åŒã®ïŒâããã ã¹ããã€ãããïŒäœã«å
åšããããã²ã³ååãé€å»ããäžè¬åŒã®ïŒãïŒ
äœã§é£œåãããã¹ããã€ãããã®äœçœ®ã§è±æ°ŽçŽ
ããäžè¬åŒã®21âã¢ã»ããã·ã¹ããã€ããå æ°Ž
å解ãåã¯äžè¬åŒã®21âããããã·ã¹ããã€ã
ããšã¹ãã«åããããšãç¹åŸŽãšããåèš6αïŒ16α
âãžã¡ãã«ã³ã«ãã³ã€ãã®è£œé æ¹æ³ã ïŒïŒ äžè¬åŒïœïŒ åŒäžçµåæãã¯åçµååã¯äºéçµåãè¡šããã
ã¯æ°ŽçŽ ååãåŒçŽ ååãå¡©çŽ åååã¯èçŽ åå
ãè¡šãããã¯æ°ŽçŽ ååãå¡©çŽ ååãããããã·
åºåã¯ã¢ã»ããã·åºãè¡šãããR2ã¯æé«ïŒåã®
ççŽ ååãæããã¢ã«ãã«åºåã¯ããšãã«åºãè¡š
ããã§ç€ºãããïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€ã
ã補é ããã«åœããäžè¬åŒïŒ åŒäžããåã³R2ã¯åèšã®ãã®ãè¡šãããR3
ã¯ççŽ ååïŒãïŒåãæããã¢ã«ãã«åºãè¡šã
ãã§ç€ºãããã¹ããã€ãã®ãªã«ããšã¹ãã«ãã
é žãããªã¡ãã«ã·ãªã«ã¯ããªãåã¯ããªããšãã«
ã¡ãã«ã¯ããªããçšããŠå解ããå Žåã«ãã€ãŠã¯
21äœã®ããããã·ããšã¹ãã«åãããåã¯æ°ŽçŽ å
ã¯å¡©çŽ ãšäº€æããã€å Žåã«ãã€ãŠã¯ïŒïŒïŒâäœã§
飜åãããã¹ããã€ãããã®äœçœ®ã§è±æ°ŽçŽ ããã
ãšãç¹åŸŽãšããåèšïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€
ãã®è£œé æ¹æ³ã ïŒïŒ äžè¬åŒïœïŒ åŒäžçµåæãã¯åçµååã¯äºéçµåãè¡šããã
ã¯æ°ŽçŽ ååãåŒçŽ ååãå¡©çŽ åååã¯èçŽ åå
ãè¡šãããã¯æ°ŽçŽ ååãå¡©çŽ ååãããããã·
åºåã¯ã¢ã»ããã·åºãè¡šãããR2ã¯æé«ïŒåã®
ççŽ ååãæããã¢ã«ãã«åºåã¯ããšãã«åºãè¡š
ããã§ç€ºãããïŒïŒ16âãžã¡ãã«ã³ã«ãã³ã€ã
ã補é ããã«åœããäžè¬åŒïŒ åŒäžããåã³R2ã¯åèšã®ãã®ãè¡šããã§
瀺ãããã¹ããã€ãã®21âã¢ã·ã«åºã転äœããã€
å Žåã«ãã€ãŠã¯21äœã®ããããã·åºããšã¹ãã«å
ãããåã¯æ°ŽçŽ åã¯å¡©çŽ ãšäº€æããã€å Žåã«ãã€
ãŠïŒïŒïŒâäœã§é£œåãããã¹ããã€ãããã®äœçœ®
ã§è±æ°ŽçŽ ããããšãç¹åŸŽãšããåèšïŒïŒ16âãžã¡
ãã«ã³ã«ãã³ã€ãã®è£œé æ¹æ³ã
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3400188.3 | 1984-01-02 | ||
DE3400188A DE3400188A1 (de) | 1984-01-02 | 1984-01-02 | Neue 6(alpha),16(alpha)-dimethylkortikoide |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60226895A JPS60226895A (ja) | 1985-11-12 |
JPH0559919B2 true JPH0559919B2 (ja) | 1993-09-01 |
Family
ID=6224360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59274249A Granted JPS60226895A (ja) | 1984-01-02 | 1984-12-27 | æ°èŠïŒÎ±ïŒïŒïŒÎ±âãžã¡ãã«ã³ã«ãã³ã€ãåã³ãã®è£œé æ¹æ³ |
Country Status (5)
Country | Link |
---|---|
US (1) | US4619922A (ja) |
EP (1) | EP0149222B1 (ja) |
JP (1) | JPS60226895A (ja) |
AT (1) | ATE58145T1 (ja) |
DE (2) | DE3400188A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60161914A (ja) * | 1984-02-02 | 1985-08-23 | Green Cross Corp:The | ã¹ããã€ãèèªé žãšã¹ãã«å«æçŽè žæäžè£œå€ |
US4968822A (en) * | 1987-12-11 | 1990-11-06 | Taisho Pharmaceutical Co., Ltd. | 21-alkoxysteroid compounds |
DE3915951C1 (ja) * | 1989-05-12 | 1990-09-13 | Schering Ag, 1000 Berlin Und 4709 Bergkamen, De | |
DE4333920A1 (de) * | 1993-10-05 | 1995-04-13 | Hoechst Ag | Corticoid-17,21-dicarbonsÀureester sowie Corticosteroid-17-carbonsÀureester-21-kohlensÀureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
US5693629A (en) * | 1994-04-04 | 1997-12-02 | Meiji Milk Products Co., Ltd. | Progesterone compound and use thereof |
CN114057821B (zh) * | 2021-11-30 | 2022-12-09 | é»éŸæ±äžå»è¯å€§åŠ | çšäºåŽç»ç»æ绌ååŸçéé žç²çŸåé ®çå¶å€æ¹æ³ |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3004994A (en) * | 1957-09-16 | 1961-10-17 | Merck & Co Inc | 6alpha, 16alpha-dimethyl-pregnenes |
US3201429A (en) * | 1958-07-12 | 1965-08-17 | Syntex Corp | 17, 21-diesters of 6alpha, 16alpha-dimethyl-delta4-pregnen-17alpha-21-diol-3, 20-dione and process therefor |
GB898292A (en) * | 1959-03-18 | 1962-06-06 | Upjohn Co | Improvements in or relating to steroids and the manufacture thereof |
US3290338A (en) * | 1959-06-01 | 1966-12-06 | Schering Corp | 16-alkylprogesterones and their 9alpha, 11beta-dihalogeno analogs |
US3054811A (en) * | 1961-09-14 | 1962-09-18 | Merck & Co Inc | Ring a unsaturated 6, 16-dimethyl steroids of the pregnane series |
US3350426A (en) * | 1962-06-14 | 1967-10-31 | Syntex Corp | 6alpha, 16alpha-dimethyl-1, 4-pregnadien-17alpha-ol-3, 20 dione and esters thereof |
GB1047518A (en) * | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ªÂ-monoesters of 11,17,21-trihydroxy steroid compounds |
DE3227312A1 (de) * | 1982-07-19 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung |
-
1984
- 1984-01-02 DE DE3400188A patent/DE3400188A1/de not_active Withdrawn
- 1984-12-22 AT AT84116169T patent/ATE58145T1/de not_active IP Right Cessation
- 1984-12-22 DE DE8484116169T patent/DE3483569D1/de not_active Expired - Lifetime
- 1984-12-22 EP EP84116169A patent/EP0149222B1/de not_active Expired - Lifetime
- 1984-12-27 JP JP59274249A patent/JPS60226895A/ja active Granted
-
1985
- 1985-01-02 US US06/688,134 patent/US4619922A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPS60226895A (ja) | 1985-11-12 |
DE3400188A1 (de) | 1985-07-11 |
ATE58145T1 (de) | 1990-11-15 |
EP0149222A2 (de) | 1985-07-24 |
EP0149222B1 (de) | 1990-11-07 |
EP0149222A3 (en) | 1986-05-14 |
DE3483569D1 (de) | 1990-12-13 |
US4619922A (en) | 1986-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6354391A (ja) | ã¹ããã€ãã®è£œæ³ | |
US4036831A (en) | Trimethyl siloxane steroid intermediates | |
US3947478A (en) | Alkylated 3,20-diketo-Î4 -steroids of the pregnane series | |
JPH0415239B2 (ja) | ||
JP2721002B2 (ja) | ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒïŒïŒïŒâãžãªã³ã®ïŒâã¡ãã¬ã³èªå°äœã®åæã«ãããæ¹è¯ | |
JPS59106500A (ja) | æ°èŠïŒÎ±âã¡ãã«ã³ã«ãã³ã€ãåã³ãã®è£œæ³ | |
KR850001208B1 (ko) | 17α-ìì€ì¥ì-5β-ìœë¥Ží°ìœìŽë ë° 17α-ìì€ì¥ì-5α-ìœë¥Ží°ìœìŽëì ì ì¡°ë°©ë² | |
JPH0559919B2 (ja) | ||
JPH033679B2 (ja) | ||
US4777165A (en) | 6α, 16β-dimethyl corticoids and their anti-inflammatory use | |
JPS6244560B2 (ja) | ||
JPH0276896A (ja) | ã¹ããã€ãååç©ããã³ãã®è£œé æ¹æ³ | |
NO773361L (no) | Fremgangsmaate ved fremstilling av corticoider | |
JPS645880B2 (ja) | ||
JPS615092A (ja) | ïŒÎ±âã¡ãã«ââãã¢âã³ã«ãã³ã€ãããã®è£œæ³ããã³ãããå«æããç®èçŸæ£æ²»çã®ããã®å»è¬èª¿å€ | |
JPS6129960B2 (ja) | ||
JPS60174798A (ja) | ïŒïŒïŒïŒïŒâïœïŒœã·ã¯ããã³ã¿ããã¬ã°ãã³é¡ | |
JPH0121840B2 (ja) | ||
JPS6044318B2 (ja) | ã¹ããã€ãã«ãïŒïŒïœïŒïŒïŒâïœãããã¿ãªã³é¡ã®è£œæ³ | |
KR800000407B1 (ko) | D-ížëªšì€í ë¡ìŽëì ì ì¡°ë°©ë² | |
JPS58132000A (ja) | æ°èŠã³ã«ãã³ã€ãããã®è£œæ³ããã³è©²ååç©ãå«æãããæçäœçšãæããè£œå€ | |
JPS5919559B2 (ja) | ã¹ããã€ãã«ãïŒïŒÎ±ïŒïŒïŒâïœãããã¿ãªã³é¡ | |
JPS6361000B2 (ja) | ||
JPS604200A (ja) | ãã¬ã°ãã³ç³»ã¹ããã€ãååç© | |
CS248728B2 (cs) | Způsob vÜroby derivátů βα-methylkortikoidu |